CVRx (CVRX) Operating Leases (2021 - 2026)

CVRx's (CVRX) quarterly Operating Leases came in at $544000.0 in Q1 2026, down 32.17% year-on-year from $802000.0 in Q1 2025, and down 14.73% quarter-over-quarter from $638000.0 in Q4 2025.

CVRx (CVRX) Operating Leases (2021 - 2026) Analysis & Trends

CVRx's Operating Leases history runs 6 years deep, the most recent figure standing at $544000.0 for Q1 2026.

  • On a quarterly basis, Operating Leases fell 32.17% year-over-year to $544000.0 in Q1 2026; TTM through Mar 2026 was $544000.0, a 32.17% decrease from a year earlier, with the FY2025 full-year figure at $638000.0, down 27.25% from the prior year.
  • Operating Leases slipped to $544000.0 in Q1 2026 per CVRX's latest filing, from $638000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $1.2 million in Q4 2023 and bottomed at $59000.0 in Q1 2023.
  • The 5-year median for Operating Leases is $802000.0 (2025), against an average of $670764.7.
  • Across the five-year window, Operating Leases tumbled 80.59% in 2023 and soared 1750.85% in 2024, its largest moves.
  • Year by year, Operating Leases stood at $117000.0 in 2022, then soared by 891.45% to $1.2 million in 2023, then declined by 24.4% to $877000.0 in 2024, then declined by 27.25% to $638000.0 in 2025, then dropped by 14.73% to $544000.0 in 2026.
  • Per Business Quant, the three latest CVRX Operating Leases figures stand at $544000.0 (Q1 2026), $638000.0 (Q4 2025), and $730000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 CVRx 128.88 Mn 56.58 Mn 12.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 544,000.00
Dec 31, 2025 638,000.00
Sep 30, 2025 730,000.00
Jun 30, 2025 819,000.00
Mar 31, 2025 802,000.00
Dec 31, 2024 877,000.00
Sep 30, 2024 951,000.00
Jun 30, 2024 1.02 Mn
Mar 31, 2024 1.09 Mn
Dec 31, 2023 1.16 Mn
Sep 30, 2023 916,000.00
Jun 30, 2023 946,000.00
Mar 31, 2023 59,000.00
Dec 31, 2022 117,000.00
Sep 30, 2022 175,000.00
Jun 30, 2022 250,000.00
Mar 31, 2022 304,000.00
Mar 31, 2021 512,000.00